Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Marie Skłodowska-Curie Actions (MSCA) COFUND doctoral programme INNOCHEMBIO (https://taltech.ee/en/innochembio), which is co-funded by the European Union (Grant agreement 101217295), offers 15 PhD
-
: 4 years No. of scholarships: 5 Coordinator: Prof. Carlo Rescigno Contact e-mail: acma@ssmeridionale.it 2. Clinical and Translational Oncology (CTO) Program duration: 4 years No. of scholarships: 5
-
to apply, please use the below Programme Application Portal to get in touch with the Programme Admission Admin. Application received in other channels will be re-directed and requires apply for a second time
-
for constraining the spin of the compact object being lensed which will involve both theoretical and computational modelling. If you wish to discuss any details of the project informally, please contact: Prof
-
represent stakeholder preferences. The integrated Research Training Group (RTG) will provide doctoral researchers with an attractive qualification program, foster networking, enable internationalization and
-
the sub-sized specimen testing program. You’ll also have the opportunity to present your work at international conferences/workshops. Finally, as a part of your graduate experience, you’ll have the
-
photonics’, led by Assoc. Prof. Thomas Christensen, who moved from MIT to DTU in 2023. Funded by a Villum Young Investigator program (link ), the project aims to uncover novel kinds of photonic topology using
-
registered select ‘Create a Postgraduate Application’. Use ‘Course Search’ to identify your programme of study: · search for the ‘Course Title’ using the programme code: 8060F · Research Area
-
by Prof. Holger Voos. Additionally, this industrial project will be conducted in partnership with the Proximus company as part of the IPBG ATLAS program. This PhD project aims to develop a solution for
-
applications. The program emphasises interdisciplinary collaboration across orthopaedics, otology, and odontology, integrating basic research with preclinical and clinical studies. In partnership with 27